ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Innovate Biopharmaceuticals Inc

Innovate Biopharmaceuticals Inc (INNT)

0.56
0.00
(0.00%)
Closed January 05 3:00PM
0.00
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.56
Bid
0.56
Ask
0.57
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.56
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

INNT Latest News

RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Dise...

RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Disease Pipeline Acquisition will add novel long-acting GLP-1 with plans...

Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac ...

CeD LA 3001 trial doses first patient in historic Phase 3 celiac disease trial RALEIGH, N.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a...

Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate Updates

Company is exploring potential strategic opportunities and non-dilutive sources of capital, and partnerships Continued activities of the first Phase 3 clinical trial for celiac disease including...

Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings Release

Innovate undertakes succession planning for a chief executive officer Finance team strengthened and well positioned for future growth Second quarter earnings release expected August 8, 2019...

Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer

RALEIGH, N.C., June 24, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune...

Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac Disease

RALEIGH, N.C., June 10, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune...

Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Lar...

Analyst Meeting to be held at 4:30pm ET today to discuss NASH data and provide clinical updates Three posters presented at DDW 2019 highlighted the protective effect and molecular mechanism of...

Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San Diego

RALEIGH, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...

Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct Offering

RALEIGH, N.C., May 01, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) today announced the closing of its previously announced registered direct offering of 4,318,272...

Innovate Biopharmaceuticals Announces $8.7 Million Registered Direct Offering Priced At-the-Market

RALEIGH, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) today announced that it has entered into securities purchase agreements with certain...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

INNT - Frequently Asked Questions (FAQ)

What is the current Innovate Biopharmaceutic... share price?
The current share price of Innovate Biopharmaceutic... is US$ 0.56
What is the 1 year trading range for Innovate Biopharmaceutic... share price?
Innovate Biopharmaceutic... has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
230.01M

Discussion

View Full Feed
mrMadMax mrMadMax 2 minutes ago
🤡"But what are you rambling about? Do you keep smoking even on Sundays? Same BS .....Why not go do your job at the circus🤡? It would be better for you and for everyone than reading this street BS nonsense."🤡
ATMH
meidiot meidiot 3 minutes ago
I have tried to inform all posters for years that GMPR is not a great investment.
MR.JAMES C VOWLER IS A LIAR
GMPR
StonkMaster StonkMaster 3 minutes ago
You'd have to think (hope) we're worth more than 1.3-1.4B upon UK approval - maybe after NICE appraisal.
NWBO
real777mellon real777mellon 4 minutes ago
Are you literally attacking me and calling me crazy for sharing my stake in a very misunderstood stock and not widely understood 2008 fallout. Listen to Tucker's guest then. Targeted yes. It was Targeted.

Don't disrespect me or Bob or anyone. You're not making me feel like I am using
LEHNQ
EdibleZone EdibleZone 4 minutes ago
Vern did buy a lot of shares at $3.80 and I don't think he would have unless he believed things would work out. Beyond that I don't know, I agree they could do a lot better on the social media front. There have been a lot of delays, but I think that's typical for a small company that needs more capi
LCTC
ChannelTrader ChannelTrader 5 minutes ago
Cutting a boot off a tire, no brake work is required...whew.

https://www.youtube.com/shorts/cb8kA3uQfbY
oldstocks oldstocks 6 minutes ago
Golf, i know how you feel but please private message me when you got a great idea how to supplement our losses while holding AFFU

I need to make up just as much as you i think and feel
AFFU
real777mellon real777mellon 6 minutes ago
I'm disappointed I came back here happy and flattered that anyone would want to email anyone here my X post.

I have never had issues here.

If you want to bully me over being "political" - I won't come back.

But if you're like those $FNMA admins - your "po
FNMA
Nelson2 Nelson2 6 minutes ago
Leading credence to IPO/Spinoff?

GLTU
BB
Monroe1 Monroe1 7 minutes ago
So you are not interested in facts? What you call conspiracy theories is a hasty generalization that is not based in fact.
BIXT
Clark6290 Clark6290 7 minutes ago
Bad link
FNMA
RickNagra RickNagra 8 minutes ago
https://x.com/ricknagra/status/1876074015389020414?s=46&t=xLP2LlWgJrEMUZZ7Fum-nA
FNMA
22rover 22rover 8 minutes ago
Found this on the sidechannel website. In the company’s estimation, Enclave is the #1 competitor to Illumio, while Cisco ranks second and VMware third. That's impressive, to say the least, when you consider that privately-held Illumio has a current valuation in the billions. It’s analogous to putti
SDCH
Acme Investments Acme Investments 8 minutes ago
You give a rough outline for business purposes!! Since you never ever even sniffed anything better than the fry rack or something that requires critical thinking you don't get it!! Many other things are happening behind the scenes!! Just like you looked up and had to read he gained custody while you
BCAP
SupernovaAstronaut88 SupernovaAstronaut88 9 minutes ago
(starting from the 20th ?)

From Monday, January 20, 2025
Added 100 days
Result: Wednesday, April 30, 2025
https://www.timeanddate.com/date/dateadded.html
FNMA
BeachBum BeachBum 9 minutes ago
You’re gonna be a millionaire
AHRO
MartinLutherKing MartinLutherKing 9 minutes ago
FDA Fast -Track status is possible https://financialpost.com/globe-newswire/transcode-therapeutics-announces-orphan-drug-designation-status-for-ttx-mc138-for-treatment-of-pancreatic-cancer
Monroe1 Monroe1 10 minutes ago
https://www.statista.com/statistics/1318652/covid-vaccine-lawsuits-industry/
PFE
INEEDMONEY INEEDMONEY 11 minutes ago
Oil! Trump in office ! This at .0001 ???? Why
PDGO
NASDAQ2020 NASDAQ2020 12 minutes ago
It was eluded to during last CC or two. There was a 30 day delay in Vyvanse approval due to getting New exclusive api suppler approved by the FDA.

High octane jet fuel for the SP.
ELTP
tdbowieknife tdbowieknife 17 minutes ago
Lol... You're easily confused.

I have never owned a single share of the serial scam.


.


Buyer Beware
Pump and Dump
http://images.investorshub.advfn.com/images/uploads/2013/12/13/fowqcCaveat_Emptor_5.JPG

GRLT